A screening for novel immune modulators identifies SIK3 kinase as a regulator of tumor resistance to T cell attack

Antonio Sorrentino
2021
Boutros M, Beckhove P. A screening for next-generation immune checkpoints identifies AS1 as novel regulator of tumor resistance to T cell attack. Cancer Immunotherapy and Immunomonitoring meeting -CITIM 04/2017. Sorrentino A, Menevse A, Michels T, Khandelwal N, Breinig M, Poschke I, Volpin V, Wagner S, Offringa R, Boutros M, Beckhove P. Discovering novel targets in a highthroughput fashion: RNAi screen for pancreatic ductal adenocarcinoma (PDAC) associated immune modulators. Cancer
more » ... Meeting -CIMT 05/2016. Poster Award. Sorrentino A, Menevse A, Michels T, Khandelwal N, Breinig M, Poschke I, Volpin V, Wagner S, Offringa R, Boutros M, Beckhove P. RNAi discovery platform to identify novel genes that prevent immune surveillance in pancreatic ductal adenocarcinoma (PDAC).
doi:10.11588/heidok.00023273 fatcat:6mqlt7zxcngvbam2bf3l7ipgea